Skip to Main Content

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.

And here is our regular feature in which we highlight a different person each week. This time around, we note that Melinta Therapeutics hired Christine Ann Miller as chief executive officer and president. Most recently, she was the global and U.S. product portfolio for the Sandoz unit at Novartis (NVS).

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!